Megan Francis‐Sedlak

Author

Horizon Therapeutics (United States)ORCID

Also Known As

M. Francis-Sedlak, Megan E. Francis-Sedlak, Megan Francis-Sedlak, Megan Francis‐Sedlak

Publications

813

Citations

H-Index

Concepts

All Affiliations

Horizon Therapeutics (United States)Illinois Institute of Technology Edward Hines, Jr. VA Hospital Cedars-Sinai Medical Center Chang Gung University

About

Megan Francis‐Sedlak is an author at Horizon Therapeutics (United States) specializing in medicine, biomedical engineering, and extracellular matrix.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	433
2	Biomedical Engineering	5	5	405
3	Engineering	3	3	271
4	Public Health	1	1	28
5	Cell Biology	1	1	87

Megan Francis‐Sedlak

Publications

770

Citations

H-Index

Page 1

	Year	Citations
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment Raymond S. Douglas, George J. Kahaly, Shoaib Ugradar, Ophthalmology	2021	148
Extraction and Assembly of Tissue-Derived Gels for Cell Culture and Tissue Engineering Shiri Uriel, Edwardine Labay, Megan Francis‐Sedlak, Tissue Engineering Part C Methods Tissue EngineeringEngineeringBiomaterials DesignBiofabricationCell Culture	2008	121
Characterization of type I collagen gels modified by glycation Megan Francis‐Sedlak, Shiri Uriel, Jeffery C. Larson, Biomaterials Biopolymer GelGlycobiologyBiomedical EngineeringMatrix BiologyMedicine	2008	101
The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering Monica L. Moya, Ming‐Huei Cheng, Jung‐Ju Huang, Biomaterials Tissue EngineeringRegenerative MedicineAdipose Tissue EngineeringVascular Tissue EngineeringAngiogenesis	2010	87
Collagen glycation alters neovascularization in vitro and in vivo Megan Francis‐Sedlak, Monica L. Moya, Jung‐Ju Huang, Microvascular Research Tissue EngineeringAngiogenesisEngineeringVascular AdaptationVascular Biology	2010	63
Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States Kimberly Cockerham, Lissa Padnick‐Silver, Noel Stuertz, Ophthalmology and Therapy	2021	61
Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration Monica L. Moya, Stephanie Lucas, Megan Francis‐Sedlak, Microvascular Research Regenerative MedicineAngiogenesisVascular AdaptationMicrovascular DysfunctionFibroblast Growth Factor	2009	33
Dermis‐derived hydrogels support adipogenesis <i>in vivo</i> Ming‐Huei Cheng, Shiri Uriel, Monica L. Moya, Journal of Biomedical Materials Research Part A	2009	29
Perspectives on urea cycle disorder management: Results of a clinician survey Gregory M. Enns, Marty H. Porter, Megan Francis‐Sedlak, Molecular Genetics and Metabolism GynecologyGenetic MedicineClinical GeneticsUrea Cycle DisordersClinical Epidemiology	2019	28
Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States Yao Wang, Anu Sharma, Lissa Padnick‐Silver, Ophthalmology and Therapy	2020	28

Page 1